Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN · Real-Time Price · USD
0.6608
-0.0702 (-9.60%)
At close: Oct 30, 2026, 4:00 PM EDT
0.6740
+0.0132 (2.00%)
After-hours: Oct 30, 2026, 7:31 PM EDT
Lantern Pharma Employees
Lantern Pharma had 16 employees as of December 31, 2025. The number of employees decreased by 8 or 33.33% compared to the previous year. That makes Lantern Pharma the 39,071st largest employer in the world and 5,677th in the United States.
Employees
16
Change (1Y)
-8
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$1,165,808
Market Cap
8.45M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 16 | -8 | -33.33% | 16 | 0 |
| Dec 31, 2024 | 24 | 3 | 14.29% | 24 | 0 |
| Dec 31, 2023 | 21 | -2 | -8.70% | 21 | 0 |
| Dec 31, 2022 | 23 | 7 | 43.75% | 22 | 1 |
| Dec 31, 2021 | 16 | 1 | 6.67% | 14 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioLineRx | 24 |
| Passage Bio | 24 |
| Lisata Therapeutics | 21 |
| IN8bio | 18 |
| BioVie | 13 |
| Actuate Therapeutics | 12 |
| Purple Biotech | 10 |
| Intensity Therapeutics | 7 |
LTRN News
- 12 days ago - Lantern Pharma Proxy statement: Proxy filing - Filings
- 16 days ago - Lantern Pharma Transcript: The ThinkEquity Conference - Transcripts
- 23 days ago - Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 15th, 2026 - Business Wire
- 23 days ago - Lantern Pharma Proxy statement: Proxy filing - Filings
- 24 days ago - Lantern receives Taiwan approval to open next stage of Phase 2 HARMONIC trial - TheFly
- 24 days ago - Lantern Pharma Receives Taiwan Approvals to Open Next Stage of Phase 2 HARMONIC™ Trial of LP-300 in Never-Smoker, EGFR-Mutant NSCLC - Business Wire
- 4 weeks ago - Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering - Business Wire
- 4 weeks ago - Lantern Pharma prices 3.67M shares at $1.09 in registered direct offering - TheFly